Piper Jaffray Would Buy Deciphera Pharmaceuticals (DCPH) Into ESMO
Tweet Send to a Friend
Piper Jaffray analyst, Christopher Raymond, reiterated his Overweight rating on shares of Deciphera (NASDAQ: DCPH) ahead of a key ESMO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE